Clinical trial
Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in…
NCT00189566 · ARCAGY/ GINECO GROUP, Other · Completed
Key facts
| NCT number | NCT00189566 |
|---|---|
| Title | Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse |
| Official title | National, Randomized, Phase II Study Comparing Efficacy of Weekly Administration of Paclitaxel in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse |
| Lead sponsor | ARCAGY/ GINECO GROUP, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Fallopian Tube Cancer, Malignant Tumor of Peritoneum |
| Intervention type | Drug |
| Interventions | Paclitaxel, Topotecan, Carboplatin |
| Enrollment | 165 |
| Start date | Apr 1, 2004 |
| Completion | Apr 1, 2009 |
| First posted | Sep 19, 2005 |
| Last update posted | Feb 25, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: